Skip to content
drillr.ai
Sign up

688098.SH

申联生物

SSE · Healthcare · Biotechnology · CN

CNY 8.00
−3.03%
Ask drillr

  • Aug 30, 2026, 07:37 UTC

    Shenlian Biotech appointed Gao Xu as deputy general manager, effective from the board meeting date until the end of the fourth board term.

    Source:

  • Aug 30, 2026, 07:36 UTC

    Shenlian Biologic reported its first-half 2026 results: revenue of 112 million yuan, down 8.05% year-on-year; net loss attributable to shareholders of 19.1464 million yuan, compared with a net loss of 12.8697 million yuan in the same period last year; non-recurring net loss of 19.1558 million yuan; R&D investment accounted for 19.91% of revenue, down 2.41 percentage points year-on-year.

    Source: